Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

Exploring Novel BCL2 and BTK Inhibitor Combinations in Frontline CLL Therapy.

Managing CLL with TP53 Mutations or del(17p): Strategies and Guidelines.

Applying Menin Inhibitor Therapy for Patients With Relapsed Acute Myeloid Leukemia.

Approaching BTK Inhibitor Resistance and Mutations in Chronic Lymphocytic Leukemia.

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.